Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2476

1.
2.

[Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].

Horký K.

Vnitr Lek. 2010 Feb;56(2):120-6. Review. Czech.

PMID:
20329582
3.

Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?

Athyros VG, Mikhailidis DP, Kakafika AI, Tziomalos K, Karagiannis A.

Expert Opin Pharmacother. 2007 Apr;8(5):529-35. Review.

PMID:
17376010
4.

[The future of renin inhibition].

Uresin AY, Baran E.

Turk Kardiyol Dern Ars. 2009 Oct;37 Suppl 7:32-8. Turkish.

5.

Aliskiren/valsartan combination for the treatment of cardiovascular and renal diseases.

Yarows SA.

Expert Rev Cardiovasc Ther. 2010 Jan;8(1):19-33. Review.

PMID:
20030022
6.

Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.

Dalla Vestra M, Simioni N, Masiero A.

Minerva Endocrinol. 2009 Dec;34(4):333-8. Review.

PMID:
20046162
7.

Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.

Rao MS.

J Assoc Physicians India. 2010 Feb;58:102-8. Review.

PMID:
20653151
8.

Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions.

Angeli F, Reboldi G, Mazzotta G, Poltronieri C, Garofoli M, Ramundo E, Biadetti A, Verdecchia P.

Curr Drug Saf. 2012 Feb;7(1):76-85. Review.

PMID:
22663961
9.

Renin inhibition in hypertension.

Gradman AH, Kad R.

J Am Coll Cardiol. 2008 Feb 5;51(5):519-28. doi: 10.1016/j.jacc.2007.10.027. Review.

10.

Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.

Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J, Pfeffer MA.

Nephrol Dial Transplant. 2009 May;24(5):1663-71. doi: 10.1093/ndt/gfn721. Epub 2009 Jan 14.

PMID:
19145003
11.

Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease.

Ram CV.

Future Cardiol. 2009 Sep;5(5):453-65. doi: 10.2217/fca.09.31. Review.

PMID:
19715410
12.

Aliskiren: an oral renin inhibitor for the treatment of hypertension.

Lam S, Choy M.

Cardiol Rev. 2007 Nov-Dec;15(6):316-23. Review.

PMID:
18090068
13.

Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension.

Doulton TW, MacGregor GA.

J Renin Angiotensin Aldosterone Syst. 2009 Dec;10(4):185-9. doi: 10.1177/1470320309342733. Epub 2009 Jul 17.

PMID:
19617273
14.

The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality.

Abassi Z, Winaver J, Feuerstein GZ.

Biochem Pharmacol. 2009 Oct 15;78(8):933-40. doi: 10.1016/j.bcp.2009.05.018. Epub 2009 May 27. Review.

PMID:
19477166
15.

Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis.

Chrysant SG, Murray AV, Hoppe UC, Dattani D, Patel S, Hsu H, Zhang J.

Curr Med Res Opin. 2008 Apr;24(4):1039-47. doi: 10.1185/030079908X280581 . Epub 2008 Feb 27.

PMID:
18307835
16.

Aliskiren and valsartan combination therapy for the management of hypertension.

Epstein BJ.

Vasc Health Risk Manag. 2010 Sep 7;6:711-22. Review.

17.

[Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].

Abassi Z, Armaly Z, Nakhoul F, Hoffman A.

Harefuah. 2008 Jun;147(6):536-42, 573. Review. Hebrew.

PMID:
18693632
18.

Is there a future for direct renin inhibitors?

Chaudhary K, Nistala R, Whaley-Connell A.

Expert Opin Investig Drugs. 2010 May;19(5):653-61. doi: 10.1517/13543781003781906. Review.

PMID:
20380486
19.

Potential benefits of aliskiren beyond blood pressure reduction.

Weintraub HS, Tran H, Schwartzbard A.

Cardiol Rev. 2011 Mar-Apr;19(2):90-4. doi: 10.1097/CRD.0b013e318204d9ae. Review.

PMID:
21285669
20.

Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.

Dietz R, Dechend R, Yu CM, Bheda M, Ford J, Prescott MF, Keefe DL.

J Renin Angiotensin Aldosterone Syst. 2008 Sep;9(3):163-75. doi: 10.1177/1470320308096411.

PMID:
18957387

Supplemental Content

Support Center